Cardiorenal syndrome - PubMed (original) (raw)
Review
. 2008 Nov 4;52(19):1527-39.
doi: 10.1016/j.jacc.2008.07.051.
Affiliations
- PMID: 19007588
- DOI: 10.1016/j.jacc.2008.07.051
Free article
Review
Cardiorenal syndrome
Claudio Ronco et al. J Am Coll Cardiol. 2008.
Free article
Abstract
The term cardiorenal syndrome (CRS) increasingly has been used without a consistent or well-accepted definition. To include the vast array of interrelated derangements, and to stress the bidirectional nature of heart-kidney interactions, we present a new classification of the CRS with 5 subtypes that reflect the pathophysiology, the time-frame, and the nature of concomitant cardiac and renal dysfunction. CRS can be generally defined as a pathophysiologic disorder of the heart and kidneys whereby acute or chronic dysfunction of 1 organ may induce acute or chronic dysfunction of the other. Type 1 CRS reflects an abrupt worsening of cardiac function (e.g., acute cardiogenic shock or decompensated congestive heart failure) leading to acute kidney injury. Type 2 CRS comprises chronic abnormalities in cardiac function (e.g., chronic congestive heart failure) causing progressive chronic kidney disease. Type 3 CRS consists of an abrupt worsening of renal function (e.g., acute kidney ischemia or glomerulonephritis) causing acute cardiac dysfunction (e.g., heart failure, arrhythmia, ischemia). Type 4 CRS describes a state of chronic kidney disease (e.g., chronic glomerular disease) contributing to decreased cardiac function, cardiac hypertrophy, and/or increased risk of adverse cardiovascular events. Type 5 CRS reflects a systemic condition (e.g., sepsis) causing both cardiac and renal dysfunction. Biomarkers can contribute to an early diagnosis of CRS and to a timely therapeutic intervention. The use of this classification can help physicians characterize groups of patients, provides the rationale for specific management strategies, and allows the design of future clinical trials with more accurate selection and stratification of the population under investigation.
Comment in
- The cardiorenal syndrome a classification into 4 groups?
van der Putten K, Bongartz LG, Braam B, Gaillard CA. van der Putten K, et al. J Am Coll Cardiol. 2009 Apr 14;53(15):1340; author reply 1340-1. doi: 10.1016/j.jacc.2008.12.042. J Am Coll Cardiol. 2009. PMID: 19358954 No abstract available. - Cardiorenal Syndrome in End-Stage Kidney Disease.
Tsuruya K, Eriguchi M, Yamada S, Hirakata H, Kitazono T. Tsuruya K, et al. Blood Purif. 2015;40(4):337-43. doi: 10.1159/000441583. Epub 2015 Nov 17. Blood Purif. 2015. PMID: 26657922
Similar articles
- [Cardiorenal syndrome, current understanding].
Ronco F, Ronco C. Ronco F, et al. Recenti Prog Med. 2009 Apr;100(4):202-13. Recenti Prog Med. 2009. PMID: 19554920 Review. Italian. - The cardiorenal syndrome.
Ronco C, Chionh CY, Haapio M, Anavekar NS, House A, Bellomo R. Ronco C, et al. Blood Purif. 2009;27(1):114-26. doi: 10.1159/000167018. Epub 2009 Jan 23. Blood Purif. 2009. PMID: 19169027 Review. - Volume overload and cardiorenal syndromes.
Ronco C, Maisel A. Ronco C, et al. Congest Heart Fail. 2010 Jul;16 Suppl 1:Si-iv; quiz Svi. doi: 10.1111/j.1751-7133.2010.00176.x. Congest Heart Fail. 2010. PMID: 20653717 - Cardiorenal syndromes: definition and classification.
Ronco C. Ronco C. Contrib Nephrol. 2010;164:33-38. doi: 10.1159/000313718. Epub 2010 Apr 20. Contrib Nephrol. 2010. PMID: 20427991 Review. - [Cardiorenal syndromes].
Késöi I, Sági B, Vas T, Pintér T, Kovács T, Wittmann I, Nagy J. Késöi I, et al. Orv Hetil. 2011 Sep 18;152(38):1520-7. doi: 10.1556/OH.2011.29212. Orv Hetil. 2011. PMID: 21896443 Review. Hungarian.
Cited by
- Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps.
Kula AJ, Bartlett D. Kula AJ, et al. Pediatr Nephrol. 2024 Sep 27. doi: 10.1007/s00467-024-06517-z. Online ahead of print. Pediatr Nephrol. 2024. PMID: 39331078 Review. - Association of life's essential 8 with chronic cardiovascular-kidney disorder: a prospective cohort study.
Huang X, Liang J, Zhang J, Fu J, Deng S, Xie W, Zheng F. Huang X, et al. BMC Public Health. 2024 Sep 9;24(1):2448. doi: 10.1186/s12889-024-19532-4. BMC Public Health. 2024. PMID: 39251953 Free PMC article. - Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension.
Iancu DG, Varga A, Cristescu L, Dumbrava RA, Stoica F, Moldovan DA, Suteu RA, Tilea I. Iancu DG, et al. Diagnostics (Basel). 2024 Aug 21;14(16):1824. doi: 10.3390/diagnostics14161824. Diagnostics (Basel). 2024. PMID: 39202312 Free PMC article. - Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy.
Li QR, Xu HY, Ma RT, Ma YY, Chen MJ. Li QR, et al. Diabetes Ther. 2024 Oct;15(10):2153-2182. doi: 10.1007/s13300-024-01641-3. Epub 2024 Aug 21. Diabetes Ther. 2024. PMID: 39167303 Free PMC article. Review. - Breaking Under Pressure: Cardiorenal Syndrome and Elevated Central Venous Pressures in Children With Heart Disease.
Floh AA, Ginter DC. Floh AA, et al. JACC Adv. 2024 May 20;3(7):100992. doi: 10.1016/j.jacadv.2024.100992. eCollection 2024 Jul. JACC Adv. 2024. PMID: 39130047 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical